血液診断の世界市場：市場規模・シェア・動向分析 (製品別・検査別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)

血液診断市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の血液診断の市場規模は2030年までに59億3,000万米ドルに達する見込みです。

2025年から2030年までのCAGRは6.6%と予測されています。血液疾患の有病率の増加と自動化された検査プロセスの採用が市場成長を促進すると予測されています。

血液診断プロセスの自動化は、ターンアラウンドタイムの短縮につながり、それによって全体的な治療レジメンを加速させています。さらに、自動化は管理ミスや診断検査にかかる全体的なコストの削減にもつながっています。したがって、今後数年間は血液学検査市場の成長を押し上げると予想されます。

血球計数装置の優位性は、客観的で高スループット、コスト効率の高い全自動分析装置の存在に起因しています。さらに、これらの血液分析装置は非典型的な結果も検出でき、赤血球分布幅、血小板分布、網状赤血球 (RET) 数、有核赤血球数などの測定可能なパラメーターを改善することができます。

ポイント・オブ・ケア (PoC) 血液学検査機器の出現は、診断と患者の転帰の改善につながりました。これらの検査機器は使いやすく、病院外でも使用可能です。このことは、血液学検査の受容性とアクセシビリティを高め、ひいては市場成長を促進すると予想されます。

製品回収と価格競争につながる激しい市場競争は、市場成長の妨げになると予想されます。2018年、ベクトン・ディッキンソン (BD) 社は、特定の検査に対する化学的干渉のため、Vacutainer EDTA採血管をリコールしました。このリコールは、食品医薬品局 (FDA) により、最も深刻なリコールであるクラスIリコールに分類され、それにより、これらのデバイスの使用が重傷または死亡を引き起こす可能性があることを示しています。このような製品リコールは市場の成長に悪影響を及ぼす可能性があります。

血液診断市場：分析概要

• 消耗品セグメントは2023年に66.0%のシェアで市場を独占し、予測期間のCAGRは6.9%で最速の成長が見込まれます。
• 血球計数分野は2024年に45.0%で最大の収益シェアを獲得。米国がん協会などの組織は、低WBC数の原因である好中球減少症などの病気や慢性疾患に対する認識を高めており、人々は頻繁にWBC検査を受けるようになっています。
• 病院部門は2024年に41.0%の最大売上シェアを占めました。これは、法医学検査室や病院の医療検査室における、疾病診断、血球数測定、違法薬物使用の検出、治療薬物レベルのモニタリング、蛋白質分析、血液型検査、甲状腺機能評価、抗体の存在検出などの血液診断の需要が伸びているためです。
• 北米の血液診断市場は市場を独占し、2024年のシェアは45.0%でした。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 血液診断市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• 血液診断市場：分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析

第4章 血液診断市場：製品別の推定・動向分析

• 市場シェア：製品別 (2024年・2030年)
• セグメントダッシュボード
• 世界の血液検査市場の展望：製品別
• 市場規模の予測と動向分析 (2018～2030年)
  • 装置
  • 消耗品

第5章 血液診断市場：検査の種類別の推定・動向分析

• 市場シェア：検査の種類別 (2024年・2030年)
• セグメントダッシュボード
• 世界の血液検査市場の展望：検査の種類別
• 市場規模の予測と動向分析 (2018～2030年)
  • 血球数
  • 血小板機能
  • ヘモグロビン
  • ヘマトクリット

第6章 血液診断市場：最終用途別の推定・動向分析

• 市場シェア：最終用途別 (2024年・2030年)
• セグメントダッシュボード
• 世界の血液検査市場の展望：最終用途別
• 市場規模の予測と動向分析 (2018～2030年)
  • 病院
  • 診断検査室
  • その他

第7章 血液診断市場：地域別の推定・動向分析

• 市場シェア：地域別 (2024年・2030年)
• 市場ダッシュボード：地域別
• 世界市場のスナップショット：地域別
• 市場規模の予測と動向分析 (2018～2030年)
• 北米
  • 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 最新動向と影響分析：主な市場参入企業別
• 企業/競合の分類
• ベンダー情勢
  • 主要な流通業者・チャネルパートナーの一覧
  • 主要顧客
  • 主要企業の市場シェア分析 (2023年)
  • Abbott
  • Beckman coulter Inc,
  • Sysmex Corporation
  • F. Hoffman-La Roche Ltd.
  • Siemens Healthineers
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Nihon Kohden Corporation
  • Bio-Rad laboratories
  • Horiba Medical
  • EKF Diagnostics

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 4 Global hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 5 Global hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 6 North America hematology diagnostics market, by Country, 2018 - 2030 (USD Million)
• Table 7 North America hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 8 North America hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 9 North America hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 10 U.S. hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 11 U.S. hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 12 U.S. hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 13 Canada hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 14 Canada hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 15 Canada hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 16 Mexico hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 17 Mexico hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 18 Mexico hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 19 Europe hematology diagnostics market, by Country, 2018 - 2030 (USD Million)
• Table 20 Europe hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 21 Europe hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 22 Europe hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 23 Germany hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 24 Germany hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 25 Germany hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 26 U.K. hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 27 U.K. hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 28 U.K. hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 29 France hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 30 France hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 31 France hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 32 Italy hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 33 Italy hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 34 Italy hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 35 Spain hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 36 Spain hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 37 Spain hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 38 Denmark hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 39 Denmark hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 40 Denmark hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 41 Sweden hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 42 Sweden hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 43 Sweden hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 44 Norway hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 45 Norway hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 46 Norway hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific hematology diagnostics market, by Country, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 51 China hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 52 China hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 53 China hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 54 Japan hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 55 Japan hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 56 Japan hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 57 India hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 58 India hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 59 India hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 60 South Korea hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 61 South Korea hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 62 South Korea hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 63 Australia hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 64 Australia hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 65 Australia hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 66 Thailand hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 67 Thailand hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 68 Thailand hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 69 Latin America hematology diagnostics market, by Country, 2018 - 2030 (USD Million)
• Table 70 Latin America hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 71 Latin America hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 72 Latin America hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 73 Brazil hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 74 Brazil hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 75 Brazil hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 76 Argentina hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 77 Argentina hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 78 Argentina hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 79 Middle East & Africa hematology diagnostics market, by Country, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 83 South Africa hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 84 South Africa hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 85 South Africa hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 89 UAE hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 90 UAE hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 91 UAE hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)
• Table 92 Kuwait hematology diagnostics market, by Product, 2018 - 2030 (USD Million)
• Table 93 Kuwait hematology diagnostics market, by Test, 2018 - 2030 (USD Million)
• Table 94 Kuwait hematology diagnostics market, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Hematology Diagnostics Market Segmentation
• Fig. 8 Market Snapshot, 2024
• Fig. 9 Market Trends & Outlook
• Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 14 Porter's Five Forces Analysis
• Fig. 15 Hematology diagnostics market: market outlook
• Fig. 16 Hematology diagnostics competitive insights
• Fig. 17 Parent market outlook
• Fig. 18 Related/ancillary market outlook.
• Fig. 19 Penetration and growth prospect mapping
• Fig. 20 Industry value chain analysis
• Fig. 21 Hematology diagnostics market driver impact
• Fig. 22 Hematology diagnostics market restraint impact
• Fig. 23 Hematology diagnostics market strategic initiatives analysis
• Fig. 24 Hematology diagnostics market: Product movement analysis
• Fig. 25 Hematology diagnostics market: Product outlook and key takeaways
• Fig. 26 Instrument market estimates and forecast, 2018 - 2030
• Fig. 27 Analyzers market estimates and forecast, 2018 - 2030
• Fig. 28 Flow cytometers market estimates and forecast, 2018 - 2030
• Fig. 29 Others market estimates and forecast, 2018 - 2030
• Fig. 30 Consumables market estimates and forecast, 2018 - 2030
• Fig. 31 Hematology diagnostics market: Test type movement analysis
• Fig. 32 Hematology diagnostics market: Test type outlook and key takeaways
• Fig. 33 Blood count market estimates and forecasts, 2018 - 2030
• Fig. 34 Platelet function market estimates and forecasts,2018 - 2030
• Fig. 35 Hemoglobin market estimates and forecasts, 2018 - 2030
• Fig. 36 Hematocrit market estimates and forecasts,2018 - 2030
• Fig. 37 Hematology diagnostics market: end-use movement analysis
• Fig. 38 Hematology diagnostics market: end-use outlook and key takeaways
• Fig. 39 Hospitals market estimates and forecasts, 2018 - 2030
• Fig. 40 Diagnostics labs market estimates and forecasts,2018 - 2030
• Fig. 41 Others market estimates and forecasts, 2018 - 2030
• Fig. 42 Global Hematology diagnostics market: Regional movement analysis
• Fig. 43 Global Hematology diagnostics market: Regional outlook and key takeaways
• Fig. 44 Global Hematology diagnostics market share and leading players
• Fig. 45 North America market share and leading players
• Fig. 46 North America: SWOT
• Fig. 47 Europe market share and leading players
• Fig. 48 Europe: SWOT
• Fig. 49 Asia Pacific market share and leading players
• Fig. 50 Asia Pacific: SWOT
• Fig. 51 Latin America market share and leading players
• Fig. 52 Latin America: SWOT
• Fig. 53 Middle East & Africa market share and leading players
• Fig. 54 Middle East & Africa: SWOT
• Fig. 55 North America, by country
• Fig. 56 North America
• Fig. 57 North America market estimates and forecasts, 2018 - 2030
• Fig. 58 U.S.
• Fig. 59 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 60 Canada
• Fig. 61 Canada market estimates and forecasts, 2018 - 2030
• Fig. 62 Europe
• Fig. 63 Europe market estimates and forecasts, 2018 - 2030
• Fig. 64 UK
• Fig. 65 UK market estimates and forecasts, 2018 - 2030
• Fig. 66 Germany
• Fig. 67 Germany market estimates and forecasts, 2018 - 2030
• Fig. 68 France
• Fig. 69 France market estimates and forecasts, 2018 - 2030
• Fig. 70 Italy
• Fig. 71 Italy market estimates and forecasts, 2018 - 2030
• Fig. 72 Spain
• Fig. 73 Spain market estimates and forecasts, 2018 - 2030
• Fig. 74 Denmark
• Fig. 75 Denmark market estimates and forecasts, 2018 - 2030
• Fig. 76 Sweden
• Fig. 77 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 78 Norway
• Fig. 79 Norway market estimates and forecasts, 2018 - 2030
• Fig. 80 Asia Pacific
• Fig. 81 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 82 China
• Fig. 83 China market estimates and forecasts, 2018 - 2030
• Fig. 84 Japan
• Fig. 85 Japan market estimates and forecasts, 2018 - 2030
• Fig. 86 India
• Fig. 87 India market estimates and forecasts, 2018 - 2030
• Fig. 88 Thailand
• Fig. 89 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 90 South Korea
• Fig. 91 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 92 Australia
• Fig. 93 Australia market estimates and forecasts, 2018 - 2030
• Fig. 94 Latin America
• Fig. 95 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 96 Brazil
• Fig. 97 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 98 Mexico
• Fig. 99 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 100 Argentina
• Fig. 101 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 102 Middle East and Africa
• Fig. 103 Middle East and Africa market estimates and forecasts, 2018 - 2030
• Fig. 104 South Africa
• Fig. 105 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 106 Saudi Arabia
• Fig. 107 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 108 UAE
• Fig. 109 UAE market estimates and forecasts, 2018 - 2030
• Fig. 110 Kuwait
• Fig. 111 Kuwait market estimates and forecasts, 2018 - 2030
• Fig. 112 Market share of key market players- Hematology diagnostics market

Hematology Diagnostics Market Growth & Trends:

The global hematology diagnostics market size is expected to reach USD 5.93 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 6.6% from 2025 to 2030. Increasing prevalence of blood disorders coupled with adoption of automated testing processes are projected to propel the market growth.

Automation of hematology diagnostics process have led to reduced turnaround time thereby accelerating the overall treatment regimen. Furthermore, automation has also led to reduced administrative errors and overall costs of diagnostic tests. Thus, it is expected to boost growth of the hematology testing market in the forthcoming years.

Dominance of hematology analyzers can be attributed to the presence of fully-automated analyzers which are objective, have high-throughput, and are cost-effective. Furthermore, these hematology analyzers can also detect atypical results and can improve measurable parameters such as red cell distribution width, platelet distribution, Reticulocyte (RET) counts, and nucleated red cells counts.

The advent of Point-Of-Care (PoC) hematology testing devices has led to improved diagnostic and patient outcomes. These devices are user-friendly and are available for use outside the hospital settings. This is anticipated to increase the acceptability and accessibility of hematology testing which, in turn, is anticipated to propel market growth.

Product recall and intense market competition leading to price wars are anticipated to hinder market growth. In 2018, Becton Dickinson (BD) and Company recalled Vacutainer EDTA Blood Collection Tubes owing to chemical interference with certain tests. This recall was classified as Class I recall, the most serious type of recall, by the Food and Drug Administration (FDA), thereby indicating that the use of these devices may cause serious injuries or death. Such product recalls can negatively affect the market growth.

Hematology Diagnostics Market Report Highlights:

• The consumables segment dominated the market with a share of 66.0% in 2023 and is also expected to witness the fastest growth with a CAGR of 6.9% in the forecast period.
• The blood count segment captured the largest revenue share at 45.0 % in 2024. Organizations such as the American Cancer Society are rising awareness about diseases and chronic conditions such as Neutropenia, which are caused low WBC counts, propelling the population towards having frequent WBCs test.
• The hospital segment held the largest revenue share of 41.0% in 2024. This is attributable to growing hematology diagnostics demand in forensic labs and hospital medical labs for disease diagnosis, blood cell counts, detecting illegal drug use, monitoring therapeutic drug levels, protein analysis, blood typing, thyroid function assessment, and detecting the presence of antibodies.
• North America hematology diagnostics market dominated the market and accounted for a 45.0 % share in 2024.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Test type
  • 1.2.3. End-use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Test type outlook
  • 2.2.3. End-use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Hematology Diagnostics Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of blood cancer
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Rising point-of-care (POC) hematological tests
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Stringent regulations
    • 3.2.2.2. High cost of product
• 3.3. Hematology Diagnostics Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. Hematology Diagnostics Market: Product Estimates & Trend Analysis

• 4.1. Product Market Share, 2024 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Hematology Testing Market by Product Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Instrument
    • 4.4.1.1. Instrument Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.2. Analyzers
      • 4.4.1.2.1. Analyzers Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.3. Flow cytometers
      • 4.4.1.3.1. Flow cytometers Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.4. Others
      • 4.4.1.4.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Consumables
    • 4.4.2.1. Consumables Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.2. Reagents
      • 4.4.2.2.1. Reagents Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.3. Strains
      • 4.4.2.3.1. Strains Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.4. Others
      • 4.4.2.4.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Hematology Diagnostics Market: Test type Estimates & Trend Analysis

• 5.1. Test type Market Share, 2024 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Hematology Testing Market by Test type Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Blood count
    • 5.4.1.1. Blood count Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Platelet function
    • 5.4.2.1. Platelet function Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Hemoglobin
    • 5.4.3.1. Hemoglobin Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Hematocrit
    • 5.4.4.1. Hematocrit Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Hematology Diagnostics Market: End-use Estimates & Trend Analysis

• 6.1. End-use Market Share, 2024 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Hematology Testing Market by End-use Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4.1. Hospitals
    • 6.4.1.1. Hospitals Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Diagnostic labs
    • 6.4.2.1. Diagnostic labs Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Others
    • 6.4.3.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Hematology Diagnostics Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. North America
  • 7.5.2. U.S.
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe
  • 7.6.2. UK
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.7. Norway
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Regulatory framework
    • 7.6.7.3. Competitive scenario
    • 7.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Regulatory framework
    • 7.6.8.3. Competitive scenario
    • 7.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.9. Denmark
    • 7.6.9.1. Key country dynamics
    • 7.6.9.2. Regulatory framework
    • 7.6.9.3. Competitive scenario
    • 7.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Asia Pacific
  • 7.7.2. Japan
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. China
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. India
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.5. Australia
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.6. South Korea
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Regulatory framework
    • 7.7.6.3. Competitive scenario
    • 7.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.7. Thailand
    • 7.7.7.1. Key country dynamics
    • 7.7.7.2. Regulatory framework
    • 7.7.7.3. Competitive scenario
    • 7.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Latin America
  • 7.8.2. Brazil
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.3. Argentina
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Regulatory framework
    • 7.8.3.3. Competitive scenario
    • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. MEA
  • 7.9.2. South Africa
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Regulatory framework
    • 7.9.2.3. Competitive scenario
    • 7.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.3. Saudi Arabia
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Regulatory framework
    • 7.9.3.3. Competitive scenario
    • 7.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.4. UAE
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Regulatory framework
    • 7.9.4.3. Competitive scenario
    • 7.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.5. Kuwait
    • 7.9.5.1. Key country dynamics
    • 7.9.5.2. Regulatory framework
    • 7.9.5.3. Competitive scenario
    • 7.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2023
  • 8.3.4. Abbott
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Beckman coulter Inc,
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Sysmex Corporation
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. F. Hoffman-La Roche Ltd.
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Siemens Healthineers
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Nihon Kohden Corporation
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Bio-Rad laboratories
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Horiba Medical
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. EKF Diagnostics
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking